Changing Landscapes
Conference & Workshops


6-7 November 2026 I Ōtautahi Christchurch


Connect. Learn. Shape the Future.

Sponsorship

CPD Points Available

General Practitioners:

The Familial Breast and Ovarian Cancer Changing Landscapes Conference has been endorsed by The Royal New Zealand College of General Practitioners (RNZCGP) and approved for up to 15 CME credits for Continuing Professional Development (CPD) purposes. Credits will be uploaded on behalf of RNZCGP Fellows. Credits are only for GP, RHM, and Dual Fellows.


Medical Scientists:

Medical Scientists attending are entitled to claim 2 CPD points per hour of contact time (attendance). To claim, a reflective learning document needs to be completed at nzimls.org.nz.


Note: if attending online, the recording will be available for 90 days following the Conference.

Sponsorship opportunities

Sponsorship provides a valuable opportunity to connect with clinicians, researchers, genetic specialists, nurses, allied health professionals, advocates, and consumers from across Aotearoa New Zealand and beyond.


We invite you to partner with Familial Breast & Ovarian Cancer: Changing Landscapes and align your organisation with a conference committed to advancing knowledge, supporting innovation, and helping shape the future of care in this fast-moving field.


See our Sponsorship Prospectus or contact rachel@conference.nz to discuss partnership opportunities.

Have a question?

We've partnered with the team at Conference Innovators to help deliver Changing Landscapes 2026.


If you have a question, please email Victoria Drinnan at victoria@conference.nz.

Organising committee

Thank you to the Conference & Workshops Organising Committee:

  • Dr Simone Petrich, Gynaecologist and Breast Surgeon, Te Whatu Ora; Chair, New Zealand Familial Breast and Ovarian Cancer Trust
  • Dr Habil, Magdalena Ratajska, Senior Research Fellow, Department of Medical Laboratory Science/School of Pharmacy, University of Otago | Ōtākou Whakaihu Waka
  • Dr Mak Sarwar, Department of Obstetrics and Gynaecology, University of Otago | Ōtākou Whakaihu Waka
  • Cindy Zaitsoff, Senior Genetic Counsellor, Genetic Health Service New Zealand
  • Fay Sowerby, Chair, Breast Cancer Cure; Secretary, Breast Cancer Aotearoa Coalition
  • Dr Nicola McKendrey, General Practitioner, Havelock North
  • Andrea Reilly, Clinical Nurse Specialist, Te Waipounamu/Te Tai o Poutini West Coast
  • Nicola Coom, Chief Executive, Cancer Society of New Zealand; Trustee, New Zealand Familial Breast and Ovarian Cancer Trust

Our Sponsors


Gold sponsor


AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Respiratory & Autoimmunity, Cardiovascular & Metabolic Disease and Oncology. The Company is also active in inflammation, infection and neuroscience through numerous collaborations. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information, please visit: www.astrazeneca.com

 Coffee cart sponsor


IGENZ Innovative Genomics is a New Zealand owned, accredited medical genetics laboratory specialising in cancer and personalised genomic testing. Working with surgeons, haematologists, oncologists and pathologists, IGENZ provides innovative testing to support informed clinical decisions and personalised patient care. Its expanding services include pharmacogenomic testing, helping clinicians identify medicines most likely to be effective while reducing potential treatment risks. Tests include Geneticure for cardiovascular related conditions, Genomind to support personalised mental health treatment, and DPYD testing for patients receiving fluoropyrimidine chemotherapy. IGENZ also offers ColoTect, a multi target stool DNA screening test designed to help detect advanced precancerous colorectal lesions and colorectal cancer earlier. For more information, please visit: www.igenz.co.nz

   Lanyard and name-badge sponsor


Awanui is New Zealand’s leading provider of laboratory and pathology services, delivering accurate and trusted medical information to more than 25,000 New Zealanders every day. With over 2,200 staff, including more than 75 pathologists, Awanui plays an important role in cancer diagnostics and patient care. Our expertise in diagnostic testing and pathology supports clinicians in the detection, diagnosis and management of cancer, helping inform treatment decisions and improving patient outcomes. Through our nationwide network of laboratories and collection centres, we are committed to supporting advances in cancer diagnostics and ensuring New Zealanders have access to high-quality pathology services, wherever they live.  For more information, please visit www.awanuilabs.co.nz

 

 

Conference supporter


Decode Science is Australia and New Zealand's genomics, and molecular biology distributor. We work to connect researchers across the region with leading global technologies, helping to bring advanced tools within reach of local labs and institutions. Our focus spans a wide range of research areas, including oncology, inherited disease, AgBio, and environmental science, and we partner with researchers and institutions throughout ANZ to support work in these fields. Through relationships with established international suppliers, we distribute equipment and consumables backed by local support, aiming to make sure researchers have access to the technology their work requires. Whether based in a major research institution or a smaller regional lab, our role is to provide a reliable local channel to the tools and platforms researchers need, backed by the technical support and service to use them effectively. For more information, please visit www.decodescience.co.nz